ICON PLC (ICLR) Stock Fundamental Analysis
USA - NASDAQ:ICLR - IE0005711209 - Common Stock
177.73 USD
-4.3 (-2.36%)
177.73 USD
0 (0%)
Overall ICLR gets a fundamental rating of 5 out of 10. We evaluated ICLR against 58 industry peers in the Life Sciences Tools & Services industry. ICLR has only an average score on both its financial health and profitability. ICLR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ICLR had positive earnings in the past year.
In the past year ICLR had a positive cash flow from operations.
Each year in the past 5 years ICLR has been profitable.
ICLR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ICLR's Return On Assets of 3.63% is fine compared to the rest of the industry. ICLR outperforms 74.14% of its industry peers.
Looking at the Return On Equity, with a value of 6.42%, ICLR is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
ICLR has a Return On Invested Capital of 6.74%. This is in the better half of the industry: ICLR outperforms 75.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ICLR is significantly below the industry average of 13.49%.
The 3 year average ROIC (5.80%) for ICLR is below the current ROIC(6.74%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROIC | 6.74% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
1.3 Margins
ICLR has a better Profit Margin (7.40%) than 70.69% of its industry peers.
In the last couple of years the Profit Margin of ICLR has declined.
ICLR's Operating Margin of 13.99% is fine compared to the rest of the industry. ICLR outperforms 74.14% of its industry peers.
ICLR's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 28.15%, ICLR is doing worse than 75.86% of the companies in the same industry.
ICLR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% |
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICLR is destroying value.
Compared to 1 year ago, ICLR has less shares outstanding
Compared to 5 years ago, ICLR has more shares outstanding
Compared to 1 year ago, ICLR has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.11 indicates that ICLR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ICLR (2.11) is comparable to the rest of the industry.
ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
ICLR has a Debt to FCF ratio of 3.53. This is in the better half of the industry: ICLR outperforms 72.41% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that ICLR is not too dependend on debt financing.
ICLR has a Debt to Equity ratio (0.31) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Altman-Z | 2.11 |
ROIC/WACC0.83
WACC8.14%
2.3 Liquidity
ICLR has a Current Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
ICLR has a worse Current ratio (1.06) than 84.48% of its industry peers.
ICLR has a Quick Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
ICLR's Quick ratio of 1.06 is on the low side compared to the rest of the industry. ICLR is outperformed by 77.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
The earnings per share for ICLR have decreased by -5.99% in the last year.
The Earnings Per Share has been growing by 15.23% on average over the past years. This is quite good.
Looking at the last year, ICLR shows a decrease in Revenue. The Revenue has decreased by -2.46% in the last year.
ICLR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.17% yearly.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
3.2 Future
The Earnings Per Share is expected to grow by 7.20% on average over the next years.
The Revenue is expected to grow by 2.41% on average over the next years.
EPS Next Y-3.7%
EPS Next 2Y1.02%
EPS Next 3Y3.55%
EPS Next 5Y7.2%
Revenue Next Year-3.61%
Revenue Next 2Y-1%
Revenue Next 3Y0.97%
Revenue Next 5Y2.41%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 13.47 indicates a correct valuation of ICLR.
Based on the Price/Earnings ratio, ICLR is valued cheaply inside the industry as 98.28% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ICLR to the average of the S&P500 Index (26.83), we can say ICLR is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 12.44, the valuation of ICLR can be described as correct.
Based on the Price/Forward Earnings ratio, ICLR is valued cheaply inside the industry as 96.55% of the companies are valued more expensively.
ICLR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.47 | ||
| Fwd PE | 12.44 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICLR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
94.83% of the companies in the same industry are more expensive than ICLR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.34 | ||
| EV/EBITDA | 11.23 |
4.3 Compensation for Growth
ICLR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.88
EPS Next 2Y1.02%
EPS Next 3Y3.55%
5. Dividend
5.1 Amount
No dividends for ICLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
177.73
-4.3 (-2.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.62%
Inst Owner Change-0.08%
Ins Owners0.65%
Ins Owner ChangeN/A
Market Cap13.82B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts78.4
Price Target212.57 (19.6%)
Short Float %2.91%
Short Ratio2.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)0%
PT rev (3m)22.52%
EPS NQ rev (1m)-0.5%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)-0.31%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.47 | ||
| Fwd PE | 12.44 | ||
| P/S | 1.71 | ||
| P/FCF | 14.34 | ||
| P/OCF | 12.12 | ||
| P/B | 1.48 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.23 |
EPS(TTM)13.19
EY7.42%
EPS(NY)14.29
Fwd EY8.04%
FCF(TTM)12.4
FCFY6.98%
OCF(TTM)14.66
OCFY8.25%
SpS104.19
BVpS120.03
TBVpS-38.28
PEG (NY)N/A
PEG (5Y)0.88
Graham Number188.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 6.98% | ||
| ROICexgc | 176.34% | ||
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% | ||
| FCFM | 11.9% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 45.31% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.92% | ||
| Profit Quality | 160.84% | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 2.11 |
F-Score6
WACC8.14%
ROIC/WACC0.83
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-3.7%
EPS Next 2Y1.02%
EPS Next 3Y3.55%
EPS Next 5Y7.2%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-3.61%
Revenue Next 2Y-1%
Revenue Next 3Y0.97%
Revenue Next 5Y2.41%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year0.82%
EBIT Next 3Y3.29%
EBIT Next 5Y4.05%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%
ICON PLC / ICLR FAQ
Can you provide the ChartMill fundamental rating for ICON PLC?
ChartMill assigns a fundamental rating of 5 / 10 to ICLR.
What is the valuation status of ICON PLC (ICLR) stock?
ChartMill assigns a valuation rating of 6 / 10 to ICON PLC (ICLR). This can be considered as Fairly Valued.
Can you provide the profitability details for ICON PLC?
ICON PLC (ICLR) has a profitability rating of 6 / 10.
How financially healthy is ICON PLC?
The financial health rating of ICON PLC (ICLR) is 5 / 10.
What is the earnings growth outlook for ICON PLC?
The Earnings per Share (EPS) of ICON PLC (ICLR) is expected to decline by -3.7% in the next year.